Comparative effectiveness of teclistamab vs real-world physician's choice of therapy in the LocoMMotion and MoMMent studies for patients with triple-class exposed relapsed/refractory multiple myeloma

被引：0

作者：

Mateos, Maria-Victoria ^{[1
]}

van de Donk, Niels ^{[2
,3
]}

Delforge, Michel ^{[4
]}

Einsele, Hermann ^{[5
]}

De Stefano, Valerio ^{[6
]}

Lindsey-Hill, Joanne ^{[7
]}

Vincent, Laure ^{[8
]}

Kirkpatrick, Suriya ^{[9
]}

Besemer, Britta ^{[10
]}

Gonzalez Garcia, Maria Esther ^{[11
]}

Karlin, Lionel ^{[12
]}

Ghilotti, Francesca ^{[13
]}

Diels, Joris ^{[14
]}

Morano, Raul ^{[15
]}

Albrecht, Claire ^{[16
]}

Strulev, Vadim ^{[14
]}

Haddad, Imene ^{[16
]}

Pei, Lixia ^{[17
]}

Kobos, Rachel ^{[17
]}

Smit, Jennifer ^{[18
]}

Slavcev, Mary ^{[19
]}

Marshall, Alexander ^{[17
]}

Weisel, Katja ^{[20
]}

Moreau, Philippe ^{[21
]}

机构：

[1] Univ Hosp Salamanca, IBSAL, CIC, CIBERONC, Salamanca, Spain

[2] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Hematol, Amsterdam, Netherlands

[3] Canc Ctr Amsterdam, Amsterdam, Netherlands

[4] Univ Leuven, Leuven, Belgium

[5] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany

[6] Catholic Univ, Fdn Policlin A Gemelli, IRCCS, Rome, Italy

[7] Nottinghamshire Univ Hosp NHS Trust, Nottingham, England

[8] CHU Montpellier, Montpellier, France

[9] Univ West England, Bristol, Avon, England

[10] Univ Hosp Tubingen, Tubingen, Germany

[11] Univ Hosp Cabuenes, Gijon, Spain

[12] Ctr Hosp Lyon Sud, Pierre Benite, France

[13] Janssen Cilag SpA, Cologno Monzese, Italy

[14] Janssen Pharmaceut NV, Beerse, Belgium

[15] Janssen Cilag, Madrid, Spain

[16] Janssen Cilag, Issy Les Moulineaux, France

[17] Janssen Res & Dev, Raritan, NJ USA

[18] Janssen Res & Dev, Spring House, PA USA

[19] Janssen Global Serv, Raritan, NJ USA

[20] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[21] Univ Hosp Hotel Dieu, Nantes, France

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-294

引用

页码：S199 / S199

页数：1

共 50 条

[1] Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Philippe Moreau
María-Victoria Mateos
Maria Esther Gonzalez Garcia
Hermann Einsele
Valerio De Stefano
Lionel Karlin
Joanne Lindsey-Hill
Britta Besemer
Laure Vincent
Suriya Kirkpatrick
Michel Delforge
Aurore Perrot
Niels W. C. J. van de Donk
Charlotte Pawlyn
Salomon Manier
Xavier Leleu
Joaquin Martinez-Lopez
Francesca Ghilotti
Joris Diels
Raúl Morano
Claire Albrecht
Vadim Strulev
Imène Haddad
Lixia Pei
Rachel Kobos
Jennifer Smit
Mary Slavcev
Alexander Marshall
Katja Weisel
Advances in Therapy, 2024, 41 : 696 - 715
[2] Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Moreau, Philippe
Mateos, Maria-Victoria
Gonzalez Garcia, Maria Esther
Einsele, Hermann
De Stefano, Valerio
Karlin, Lionel
Lindsey-Hill, Joanne
Besemer, Britta
Vincent, Laure
Kirkpatrick, Suriya
Delforge, Michel
Perrot, Aurore
van de Donk, Niels W. C. J.
Pawlyn, Charlotte
Manier, Salomon
Leleu, Xavier
Martinez-Lopez, Joaquin
Ghilotti, Francesca
Diels, Joris
Morano, Raul
Albrecht, Claire
Strulev, Vadim
Haddad, Imene
Pei, Lixia
Kobos, Rachel
Smit, Jennifer
Slavcev, Mary
Marshall, Alexander
Weisel, Katja
ADVANCES IN THERAPY, 2024, 41 (02) : 686 - 695
[3] Updated Comparative Effectiveness of Talquetamab vs Real-World Physician's Choice of Treatment in LocoMMotion and MoMMent for Patients With Triple-Class Exposed Relapsed/ Refractory Multiple Myeloma
Einsele, Hermann
Moreau, Philippe
Bahlis, Nizar J.
Bhutani, Manisha
Vincent, Laure
Karlin, Lionel
Perrot, Aurore
Goldschmidt, Hartmut
van de Donk, Niels
Ocio, Enrique
Martinez-Lopez, Joaquin
Rodriguez-Otero, Paula
Dytfeld, Dominik
Diels, Joris
Strulev, Vadim
Haddad, Imene
Renaud, Thomas
Cabrieto, Jedelyn
Perualila, Nolen
Ammann, Eric
Parekh, Trilok
Albrecht, Claire
Weisel, Katja
Mateos Manteca, Maria-Victoria
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S50 - S51
[4] Comparative effectiveness of teclistamab versus real-world physician's choice of therapy for patients with triple-class exposed relapsed/refractory multiple myeloma
Krishnan, Amrita
Nooka, Ajay
Chari, Ajai
Garfall, Alfred
Martin, Thomas
Nair, Sandhya
Lin, Xiwu
Qi, Keqin
Londhe, Anil
Pei, Lixia
Ammann, Eric
Kobos, Rachel
Smit, Jennifer
Parekh, Trilok
Marshall, Alexander
Slavcev, Mary
Usmani, Saad
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S174 - S174
[5] Comparative efficacy of teclistamab versus real-world physician's choice of therapy in the prospective LocoMMotion study in patients with triple-class exposed relapsed/refractory multiple myeloma
van de Donk, Niels W. C. J.
Moreau, Philippe
Delforge, Michel
Einsele, Hermann
Ghilotti, Francesca
Diels, Joris
Elsada, Ahmed
Strulev, Vadim
Pei, Lixia
Kobos, Rachel
Smit, Jennifer
Marshall, Alexander
Slavcev, Mary
Weisel, Katja
Mateos, Maria-Victoria
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S33 - S34
[6] Teclistamab versus real-world physician's choice of therapy in triple-class exposed relapsed/refractory multiple myeloma
Krishnan, Amrita
Nooka, Ajay K.
Chari, Ajai
Garfall, Alfred L.
Martin, Thomas G.
Nair, Sandhya
Lin, Xiwu
Qi, Keqin
Londhe, Anil
Pei, Lixia
Ammann, Eric
Kobos, Rachel
Smit, Jennifer
Parekh, Trilok
Marshall, Alexander
Slavcev, Mary
Usmani, Saad Z.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (06)
[7] COMPARATIVE EFFECTIVENESS OF TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN'S CHOICE OF THERAPY (RWPC) FOR PATIENTS WITH TRIPLE-CLASS EXPOSED (TCE) RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
Krishnan, A.
Nooka, A.
Chari, A.
Garfall, A. L.
Martin, T.
Nair, S.
Lin, X.
Qi, K.
Londhe, A.
Pei, L.
Ammann, E.
Chastain, K.
Parekh, T.
Marshall, A.
Slavcev, M.
Usmani, S. Z.
VALUE IN HEALTH, 2023, 26 (12) : S37 - S37
[8] Updated Comparative Effectiveness of Talquetamab vs Real-world Physician's Choice of Treatment in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Ye, Jing Christine
Biran, Noa
Nair, Sandhya
Lin, Xiwu
Qi, Keqin
Ammann, Eric
Renaud, Thomas
Kane, Colleen
Parekh, Trilok
Gray, Kathleen
Zhang, Xinke
Costa, Luciano
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S99 - S100
[9] Talquetamab Versus Real-World Physician's Choice Treatment: Comparative Effectiveness in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Ye, Jing Christine
Biran, Noa
Nair, Sandhya
Lin, Xiwu
Qi, Keqin
Londhe, Anil
Ammann, Eric
Renaud, Thomas
Kane, Colleen
Parekh, Trilok
Gray, Kathleen
Peterson, Steve
Costa, Luciano J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (02):
[10] Comparative effectiveness of teclistamab versus real-world treatments for patients with triple-class exposed (TCE), relapsed/refractory multiple myeloma (RRMM).
Krishnan, Amrita Y.
Nooka, Ajay K.
Chari, Ajai
Garfall, Alfred L.
Martin, Thomas G.
Nair, Sandhya
Lin, Xiwu
Qi, Keqin
Londhe, Anil
Pei, Lixia
Eric, Ammann
Kobos, Rachel
Smit, Jennifer
Parekh, Trilok V.
Slavcev, Mary
Usmani, Saad Zafar
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

← 1 2 3 4 5 →